Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1997-1-3
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0028-2766
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
73
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
715
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8856281-Adolescent,
pubmed-meshheading:8856281-Cyclophosphamide,
pubmed-meshheading:8856281-Female,
pubmed-meshheading:8856281-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8856281-Humans,
pubmed-meshheading:8856281-Immunosuppressive Agents,
pubmed-meshheading:8856281-Leukopenia,
pubmed-meshheading:8856281-Lupus Erythematosus, Systemic
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Treatment of severe leukopenia with RHG-CSF in systemic lupus erythematosus treated with cyclophosphamide.
|
| pubmed:publicationType |
Letter,
Case Reports
|